Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

This trial found that an intradialytic cycling programme did not improve health-related quality of life compared with usual care.

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Sharlene A Greenwood 1,2,*, Pelagia Koufaki 3, Jamie H Macdonald 4, Catherine Bulley 3, Sunil Bhandari 5, James O Burton 6, Indranil Dasgupta 7, Kenneth Farrington 8, Ian Ford 9, Philip A Kalra 10, Mick Kumwenda 11, Iain C Macdougall 1,2, Claudia-Martina Messow 9, Sandip Mitra 12, Chante Reid 1, Alice C Smith 13, Maarten W Taal 14, Peter C Thomson 15, David C Wheeler 16,17, Claire White 1, Magdi Yaqoob 18, Thomas H Mercer 3

1 King’s College Hospital NHS Foundation Trust, London, UK
2 School of Renal Medicine, King’s College London, London, UK
3 School of Health Sciences, Queen Margaret University, Edinburgh, UK
4 School of Sport, Health and Exercise Sciences, Bangor University, Bangor, UK
5 Hull University Teaching Hospitals NHS Trust, Hull, UK
6 Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
7 University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
8 Lister Hospital, Stevenage, UK
9 Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
10 Salford Royal Hospital, Salford, UK
11 Glan Clwyd Hospital, Bodelwyddan, UK
12 Manchester University Hospitals, Manchester, UK
13 Department of Health Sciences, University of Leicester, Leicester, UK
14 School of Medicine, University of Nottingham, Nottingham, UK
15 Queen Elizabeth University Hospital, Glasgow, UK
16 School of Medicine, University College London, London, UK
17 George Institute for Global Health, Sydney, NSW, Australia
18 Royal London Hospital, London, UK
* Corresponding author Email: sharlene.greenwood@nhs.net

Declared competing interests of authors: David C Wheeler reports personal fees from Amgen Inc. (Thousand Oaks, CA, USA), AstraZeneca plc (Cambridge, UK), Bayer AG (Leverkusen, Germany), C.H. Boehringer Sohn AG & Co. KG (Ingelheim am Rhein, Germany), GlaxoSmithKline plc (Brentford, UK), Janssen Pharmaceuticals (Beerse, Belgium), Mundipharma International Ltd (Cambridge, UK), Napp Pharmaceutical Group Ltd (Cambridge, UK), Merck Sharp & Dohme Corp. (Kenilworth, NJ, USA), Astellas Pharma Inc. (Tokyo, Japan), Tricida (South San Francisco, CA, USA) and Vifor Fresenius Medical Care Renal Pharma Ltd (Glattbrugg, Switzerland). Sandip Mitra’s research is supported by National Institute for Health Research Infrastructure in Manchester and D4D MIC (Devices for dignity national MedTech and In vitro diagnostic Co-operatives) Sheffield.

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document